Members Members Residents Job Board
Join Today Renew Your Membership Make A Donation
2003 Abstract: 18-FDG PET AS FACTOR IN PREDICTING SURVIVAL OF PATIENTS WITH PANCREATIC CARCINOMA
AbstractID – 107147 Presentation Preference – Oral
Resident's Prize
Category – Pancreas (S9)  

18-FDG PET AS FACTOR IN PREDICTING SURVIVAL OF PATIENTS WITH PANCREATIC CARCINOMA.

Cosimo Sperti, Claudio Pasquali, Franca Chierichetti, Domenico Decet, Andrea Ferronato, Sergio Pedrazzoli Prof., PADOVA, Italy; Castelfranco Veneto (TV), Italy.

The prognosis of patients with pancreatic adenocarcinoma is usually very poor; the prediction of survival by clinicopathologic features is often difficult. Recently, the uptake of 18-FDG in PET scan has been found to be correlated with survival in patients with pancreatic cancer. Aim of this study was to evaluate the role of 18-FDG PET as prognostic factor for the patients with pancreatic adenocarcinoma. From 1996 to 2001 48 out of 106 patients who had a PET scan in the preoperative work-up for pancreatic cancer, received also an additional abdominal PET scan with semiquantitative analysis of the uptake. The standardized uptake value (SUV: n.v <2.5) was obtained, and the patients were divided in two groups, according to pathological SUV < or > 4. Patients were evaluated according to TNM (UICC) classification, gradig of the tumor, and type of operation. Survival curves were prepared using the Kaplan-Meier method, and statistical comparisons were made by log-rank test. A Cox proportional-hazards analysis was used to determine the independent variables that influenced survival. Significance was considered as p< 0.05. Results: There were 25 males and 23 females, with mean age 66.3 years (range 48-82 years). Fifteen patients underwent pancreatic resection, 15 bypass surgery, and 18 were not operated. According to TNM staging the patients were found as follows: stage I in 2 patients, stage III in 14, stage IVa in 14, and stage IVb in 18. Twelve patients showed a well differentiated tumor while 21 had a moderate and 15 a poor differentiated or undifferentiated tumor. Twenty-five cancers showed SUV values < 4, and 23 SUV > 4. Survival was significantly influenced by tumor stage (p < 0.001) when divided in two groups (stage IVb vs. stage IVa, III and I), grading (p= 0.007) and by SUV value (p=0.01). Multivariate analysis showed that stage (p=0.004), grading (p= 0.005), and SUV (p= 0.032) were independent predictors of survival. When the patients analyzed for SUV value, were stratified according to TNM stage, FDG uptake was related to survival (p=0.023) only in those patients without distant metastases. Conclusions: SUV determination in abdominal FDG-PET provides informations of prognostic relevance in patients with pancreatic cancer before surgery or medical treatment, and may therefore be useful in the selection of patients for therapeutic management.

 




Society for Surgery of the Alimentary Tract

Facebook Twitter YouTube

Email SSAT Email SSAT
500 Cummings Center, Suite 4400, Beverly, MA 01915 500 Cummings Center
Suite 4400
Beverly, MA 01915
+1 978-927-8330 +1 978-927-8330
+1 978-524-0498 +1 978-524-0498
Links
About
Membership
Publications
Newsletters
Annual Meeting
Join SSAT
Job Board
Make a Pledge
Event Calendar
Awards